BLG

12.5%

2.7¢ bluglass limited

BLG chart, page-349

First 349 Last

Share
Profile

Follow
macssharesforfun

3,005 Posts.

639

13/11/23

07:48

Post #: 70858809
Share

Originally posted by Holdtight: ↑

Here is also for the newbie.

(1) The CLAWS allocation this year is $39m between 8 parties. The split is yet to be determined. However, other than BLG, the other 7 are billion dollar market cap companies. Unconfirmed info floating around, suggest BLG has a major roll to play in a significant amount of the expected progress. An equal split will allocate $5m USD ( $7.8m AUD ) to BLG.
(2) Over the following 4 years the DoD $2.2B will be spent. Again assuming an equal distribution as this year between consortiums, $77m will be allocated to CLAWS for 4 more years. Again assuming an equal split, thats $9.625USD ( $15m AUD ) to BLG each year.
(3) The R+D is taking a little longer than expected as it is larger than previous years. It is expected to be $7.3m up from $4m. WORST CASE, the $4m will be coming from the ATO.
(4) The company is still expecting new orders and repeat orders prior to the end of the year which increase revenue and reduced the burn
(5) Prior quarters burn were one off quarters to develop the purchased Fab. Further, costs are expected to fall significantly in coming quarters as production is brought in house. THUS, reducing the burn further.
(6) Short term borrowing is available this year and next against the Australian R+D to facilitate any cash flow mismatch. Once the allocation from CLAWS is certified, I am sure there will be plenty of lenders against those 4 years of grants.

So, there is no need for a CR and quite possible may not CR again if things go as planned. What I have not included above is how much revenue comes from the products to the DoD that they purchase. This number could be anything, but given the grant size its hard to imagine that it is small!!! This money above is simply for R+D!!!!

People taking about CR clearly do not understand the business plan and the new management and are either bitter long term holders or trying to get prices lower to buy back in!!! IMHO.

Holdtight as when the R+D does drop with new orders and the claws money allocation, the market will re rate like WBT did in 2020

Expand

Its a nice summary, @Holdtight, but it ignores the main, short-term problem - if there is a problem with the ATO review of the R&D rebate, the company will have to urgently seek funding as an alternative.

Given their publicly declared, available cash, my 'timeline of concern' is not the next 3-6 months - its the NEXT 30 DAYS.

For the third time, lets hope the R&D rebate, of whatever amount, lands 'soon'er rather than later. Remember, directors have a responsibility to keep the market informed so let's hope an announcement arrives in the next few days.

As for your cheap shot, well it is what it is.....

GLTAH.

BLG Price at posting: 6.8¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

HLX

Helix investor makes partial takeover bid, proposing board changes

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

There are more pages in this discussion • 545 more messages in this thread...

First 349 Last

Add BLG (ASX) to my watchlist

(20min delay)
Last 2.7¢		Change 0.003(12.5%)		Mkt cap ! $49.33M

Open	High	Low	Value	Volume
2.5¢	2.8¢	2.5¢	$67.86K	2.700M

Buyers (Bids)

No.	Vol.	Price($)
2	55939	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	185791	4

View Market Depth

No.	Vol.	Price($)
1	50000	0.027
2	1216969	0.026
1	9601	0.025
3	38259	0.024
2	110000	0.023

Price($)	Vol.	No.
0.028	185791	4
0.029	1119912	4
0.030	135000	3
0.031	282312	4
0.032	261000	2

Last trade - 15.53pm 30/08/2024 (20 minute delay)

BLG (ASX) Chart

BLG chart, page-349

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Lendlease sells off US east coast construction operations in latest global divestment push

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Helix investor makes partial takeover bid, proposing board changes

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

BLG chart, page-349

Top Stories

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Lendlease sells off US east coast construction operations in latest global divestment push

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Helix investor makes partial takeover bid, proposing board changes

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News